These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37398299)

  • 1. H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.
    Garcia-Fabiani MB; Haase S; Banerjee K; McClellan B; Zhu Z; Mujeeb A; Li Y; Yu J; Kadiyala P; Taher A; Núñez FJ; Alghamri MS; Comba A; Mendez FM; Nicola Candia AJ; Salazar B; Koschmann C; Nunez FM; Edwards M; Qin T; Sartor MA; Lowenstein PR; Castro MG
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.
    Haase S; Banerjee K; Mujeeb AA; Hartlage CS; Núñez FM; Núñez FJ; Alghamri MS; Kadiyala P; Carney S; Barissi MN; Taher AW; Brumley EK; Thompson S; Dreyer JT; Alindogan CT; Garcia-Fabiani MB; Comba A; Venneti S; Ravikumar V; Koschmann C; Carcaboso ÁM; Vinci M; Rao A; Yu JS; Lowenstein PR; Castro MG
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36125896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    Morris M; Driscoll M; Henson JW; Cobbs C; Jiang L; Gocke CD; Chen L; Rodriguez FJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1038-1043. PubMed ID: 32954438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
    Haque F; Varlet P; Puntonet J; Storer L; Bountali A; Rahman R; Grill J; Carcaboso AM; Jones C; Layfield R; Grundy RG
    Acta Neuropathol Commun; 2017 Jun; 5(1):45. PubMed ID: 28587626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas.
    Pinto L; Baidarjad H; Entz-Werlé N; Van Dyck E
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
    Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
    J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants.
    Bressan RB; Southgate B; Ferguson KM; Blin C; Grant V; Alfazema N; Wills JC; Marques-Torrejon MA; Morrison GM; Ashmore J; Robertson F; Williams CAC; Bradley L; von Kriegsheim A; Anderson RA; Tomlinson SR; Pollard SM
    Cell Stem Cell; 2021 May; 28(5):877-893.e9. PubMed ID: 33631116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
    Chen CCL; Deshmukh S; Jessa S; Hadjadj D; Lisi V; Andrade AF; Faury D; Jawhar W; Dali R; Suzuki H; Pathania M; A D; Dubois F; Woodward E; Hébert S; Coutelier M; Karamchandani J; Albrecht S; Brandner S; De Jay N; Gayden T; Bajic A; Harutyunyan AS; Marchione DM; Mikael LG; Juretic N; Zeinieh M; Russo C; Maestro N; Bassenden AV; Hauser P; Virga J; Bognar L; Klekner A; Zapotocky M; Vicha A; Krskova L; Vanova K; Zamecnik J; Sumerauer D; Ekert PG; Ziegler DS; Ellezam B; Filbin MG; Blanchette M; Hansford JR; Khuong-Quang DA; Berghuis AM; Weil AG; Garcia BA; Garzia L; Mack SC; Beroukhim R; Ligon KL; Taylor MD; Bandopadhayay P; Kramm C; Pfister SM; Korshunov A; Sturm D; Jones DTW; Salomoni P; Kleinman CL; Jabado N
    Cell; 2020 Dec; 183(6):1617-1633.e22. PubMed ID: 33259802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in
    Yadav RK; Jablonowski CM; Fernandez AG; Lowe BR; Henry RA; Finkelstein D; Barnum KJ; Pidoux AL; Kuo YM; Huang J; O'Connell MJ; Andrews AJ; Onar-Thomas A; Allshire RC; Partridge JF
    Elife; 2017 Jul; 6():. PubMed ID: 28718400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors.
    Sangatsuda Y; Miura F; Araki H; Mizoguchi M; Hata N; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Arai Y; Yoshida A; Shibata T; Yoshimoto K; Iihara K; Ito T
    Sci Rep; 2020 Sep; 10(1):16162. PubMed ID: 32999376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STINGing the immune system: lessons learned through a model of G34-mutant pediatric high-grade glioma.
    Hall CP; Cronk JC; Rubens JA
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36377657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma.
    Mendez F; Kadiyala P; Nunez FJ; Carney S; Nunez FM; Gauss JC; Ravindran R; Pawar S; Edwards M; Garcia-Fabiani MB; Haase S; Lowenstein PR; Castro MG
    Clin Cancer Res; 2020 Aug; 26(15):4080-4092. PubMed ID: 32332014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
    Gessi M; Gielen GH; Hammes J; Dörner E; Mühlen AZ; Waha A; Pietsch T
    J Neurooncol; 2013 Mar; 112(1):67-72. PubMed ID: 23354654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-grade gliomas with H3 G34R mutation: a clinicopathological study].
    Wang W; Wang LM; Lu DH; Piao YS; Xiong YL; Zhao LH; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1267-1271. PubMed ID: 33287511
    [No Abstract]   [Full Text] [Related]  

  • 16. Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors.
    Giacomini G; Piquet S; Chevallier O; Dabin J; Bai SK; Kim B; Siddaway R; Raught B; Coyaud E; Shan CM; Reid RJD; Toda T; Rothstein R; Barra V; Wilhelm T; Hamadat S; Bertin C; Crane A; Dubois F; Forne I; Imhof A; Bandopadhayay P; Beroukhim R; Naim V; Jia S; Hawkins C; Rondinelli B; Polo SE
    Nucleic Acids Res; 2024 Mar; 52(5):2372-2388. PubMed ID: 38214234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.
    Yoshimoto K; Hatae R; Sangatsuda Y; Suzuki SO; Hata N; Akagi Y; Kuga D; Hideki M; Yamashita K; Togao O; Hiwatashi A; Iwaki T; Mizoguchi M; Iihara K
    Brain Tumor Pathol; 2017 Jul; 34(3):103-112. PubMed ID: 28447171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas.
    Gianno F; Antonelli M; Di Dio T; Minasi S; Donofrio V; Buccoliero AM; Gardiman MP; Pollo B; Diomedi Camassei F; Rossi S; Novello M; Giangaspero F; Arcella A; Gessi M; Buttarelli FR
    Am J Surg Pathol; 2021 Feb; 45(2):200-204. PubMed ID: 33428336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
    Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
    Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles' Heel.
    Huchedé P; Leblond P; Castets M
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.